Trials / Completed
CompletedNCT00102817
Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
Somatropin (Norditropin) in Children With Growth Failure Associated With ICF Deficiency.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 3 Years – 13 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in the United States of America (USA). This is a 12 month study to determine if Norditropin is safe and effective in children with IGF deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2005-02-02
- Last updated
- 2017-01-18
Locations
27 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00102817. Inclusion in this directory is not an endorsement.